Elekta (OTCMKTS:EKTAY) Shares Gap Up – Should You Buy?

Elekta AB (OTCMKTS:EKTAY) gapped up before the market opened on Friday . The stock had previously closed at $5.7150, but opened at $6.04. Elekta shares last traded at $6.04, with a volume of 5,605 shares trading hands.

Elekta Stock Performance

The business’s 50-day moving average is $6.06 and its 200-day moving average is $5.75. The company has a market capitalization of $2.23 billion, a PE ratio of -603.40 and a beta of 1.08. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.95.

Elekta (OTCMKTS:EKTAY) last issued its earnings results on Thursday, March 5th. The company reported $0.09 EPS for the quarter. The business had revenue of $433.29 million during the quarter. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.84%. On average, research analysts anticipate that Elekta AB will post 0.36 earnings per share for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.